Waters Corp
NYSE:WAT

Watchlist Manager
Waters Corp Logo
Waters Corp
NYSE:WAT
Watchlist
Price: 373.47 USD 1.35% Market Closed
Market Cap: 22.2B USD
Have any thoughts about
Waters Corp?
Write Note

Waters Corp
Current Portion of Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Waters Corp
Current Portion of Long-Term Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Current Portion of Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
Waters Corp
NYSE:WAT
Current Portion of Long-Term Debt
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Thermo Fisher Scientific Inc
NYSE:TMO
Current Portion of Long-Term Debt
$4.1B
CAGR 3-Years
501%
CAGR 5-Years
44%
CAGR 10-Years
3%
Danaher Corp
NYSE:DHR
Current Portion of Long-Term Debt
$1.2B
CAGR 3-Years
456%
CAGR 5-Years
2%
CAGR 10-Years
33%
Mettler-Toledo International Inc
NYSE:MTD
Current Portion of Long-Term Debt
$185.8m
CAGR 3-Years
51%
CAGR 5-Years
31%
CAGR 10-Years
4%
Agilent Technologies Inc
NYSE:A
Current Portion of Long-Term Debt
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
IQVIA Holdings Inc
NYSE:IQV
Current Portion of Long-Term Debt
$1.2B
CAGR 3-Years
137%
CAGR 5-Years
66%
CAGR 10-Years
50%
No Stocks Found

Waters Corp
Glance View

Market Cap
22.2B USD
Industry
Life Sciences Tools & Services

Waters Corporation is a global leader in analytical instruments and software, primarily serving the life sciences, food and beverage, chemical, and environmental industries. Founded in 1958 and headquartered in Milford, Massachusetts, Waters specializes in liquid chromatography and mass spectrometry, technologies pivotal for precise molecular analysis. As demand for accurate testing and quality assurance continues to rise across various sectors, Waters has positioned itself as an essential partner for researchers and manufacturers alike. Their innovative products, including the acclaimed ACQUITY UPLC® and SYNAPT® systems, empower scientists to tackle complex challenges, driving advancements in drug development and quality control. Investors should appreciate Waters Corp.'s steadfast commitment to research and development, which has fostered a rich pipeline of cutting-edge solutions and sustained revenue growth. The company boasts a robust customer base, ranging from academic institutions to pharmaceutical giants, which not only stabilizes income but also provides diverse avenues for expansion. With a strategic focus on emerging markets and an emphasis on sustainability, Waters is well poised to capitalize on the increasing global emphasis on health and safety standards. As the company continues to leverage its technological prowess and expertise, it remains a compelling investment opportunity for those looking to tap into the evolving landscape of analytical science.

WAT Intrinsic Value
261.87 USD
Overvaluation 30%
Intrinsic Value
Price

See Also

What is Waters Corp's Current Portion of Long-Term Debt?
Current Portion of Long-Term Debt
0 USD

Based on the financial report for Sep 28, 2024, Waters Corp's Current Portion of Long-Term Debt amounts to 0 USD.

Back to Top